Micah Benson

Micah Benson has more than 15 years of industry and academic experience as an expert immunologist and drug hunter. Prior to joining KSQ Therapeutics, Micah served as Head of Tolerance Therapeutics in the Immunology and Inflammation Research Unit at Pfizer, Inc. In this capacity, Micah was responsible for building and overseeing a drug discovery portfolio and identifying and seeding external research opportunities with biopharma partners focused on immune tolerance induction technologies. This included leading innovative approaches encompassing biologic, targeted drug delivery and cell therapy modalities, and working with patient advocacy groups to seed new opportunities in the immune tolerance space.

He earned his PhD in Immunology from Dartmouth Medical School in Dr. Randy Noelle's lab, where he discovered factors driving T regulatory cell differentiation, and was a Leukemia Lymphoma Society postdoctoral fellow at Harvard Medical School in Anjana Rao's lab, where he worked on mRNA splicing factors in B lymphocytes. He has authored several patents and published extensively in top-tier scientific journals.